Company Overview

Horizon Technology Finance Corporation (NASDAQ: HRZN) is a specialty finance company structured as a business development company (BDC) that provides secured loans and venture debt financing to venture-backed and growth-stage companies. The company primarily operates in the technology, life sciences, healthcare information and services, sustainability, and advanced manufacturing sectors. HRZN’s core business model centers on generating income through interest payments, fees, and warrants associated with debt investments in privately held companies that are typically backed by institutional venture capital and private equity sponsors.

The company’s principal revenue drivers include floating-rate and fixed-rate secured loans, equipment financing arrangements, and equity-related upside from warrant positions in portfolio companies. HRZN differentiates itself through its focus on venture lending, a niche financing market where borrowers often seek non-dilutive capital to extend operating runway while preserving equity ownership. Founded in 2010 and externally managed by Horizon Technology Finance Management LLC, the company evolved as a specialized lender targeting innovation-driven sectors that may have limited access to conventional bank financing.

Business Operations

HRZN conducts its operations through a single primary investment platform focused on originating and managing debt investments for venture-backed companies. Its investment portfolio generally consists of senior secured loans, venture loans, equipment loans, and equity warrants. The company generates revenue primarily from interest income, commitment and facility fees, end-of-term payments, and realized gains from warrant or equity investments. As a regulated BDC under the Investment Company Act of 1940, HRZN distributes a substantial portion of its taxable income to shareholders through dividends.

The company’s investment activity is concentrated primarily within the United States, although some portfolio companies maintain international operations. HRZN relies on relationships with venture capital firms, private equity sponsors, and technology ecosystems to source transactions. The company is externally managed by Horizon Technology Finance Management LLC, which oversees underwriting, portfolio management, and capital allocation. HRZN also maintains access to institutional credit facilities and securitized financing arrangements that support portfolio growth and liquidity management.

Strategic Position & Investments

HRZN’s strategic direction emphasizes expanding its venture lending platform while maintaining disciplined credit underwriting and sector specialization. The company has focused on industries with long-term innovation trends, including biotechnology, healthcare technology, enterprise software, cloud infrastructure, robotics, and sustainable technology solutions. Management has consistently highlighted recurring income generation, portfolio diversification, and preservation of capital as central strategic priorities.

The company has continued to invest in floating-rate debt structures and venture-backed enterprises that can benefit from institutional sponsor support and scalable business models. HRZN also maintains selective warrant and equity participation rights that may provide capital appreciation if portfolio companies achieve liquidity events such as acquisitions or public offerings. Its investment approach positions the company within the broader alternative credit and venture finance markets, where specialized underwriting expertise and sponsor relationships can create competitive advantages relative to traditional commercial lenders.

Geographic Footprint

HRZN is headquartered in Farmington, Connecticut, and its operations are primarily concentrated in the United States. The company’s investment activity spans major innovation and venture capital markets, including regions associated with technology and life sciences development such as California, Massachusetts, New York, and other established startup ecosystems. While HRZN itself operates principally domestically, many of its portfolio companies conduct business internationally or maintain global customer bases.

The company’s market exposure reflects broader participation in sectors with multinational commercial activity, particularly software, healthcare innovation, and advanced technology manufacturing. HRZN’s lending and investment influence is therefore indirectly connected to international growth trends through the operational expansion of its portfolio companies across North America, Europe, and parts of Asia-Pacific.

Leadership & Governance

HRZN is led by an executive team with experience in venture lending, structured finance, and investment management. The company’s governance framework reflects its structure as an externally managed BDC, with strategic oversight provided by executive management and an independent board of directors. Leadership has emphasized disciplined underwriting, long-term shareholder income generation, and support for innovation-oriented companies operating in high-growth sectors.

Key executives include:

• Robert D. Pomeroy, Jr. – Chairman and Chief Executive Officer
• Gerald A. Michaud – President
• Daniel R. Trolio – Chief Financial Officer
• Christopher M. Mathieu – Chief Accounting Officer
• Nicholas M. Pappas – General Counsel and Chief Compliance Officer

Management has consistently communicated a strategy centered on balancing portfolio growth with risk management, maintaining recurring dividend capacity, and leveraging relationships within the venture capital ecosystem to source investment opportunities.